Free Trial

enGene (ENGNW) Competitors

$1.52 -0.37 (-19.58%)
(As of 11/21/2024 ET)
No competitors for enGene were found.

Get enGene News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENGNW and its competitors with MarketBeat's FREE daily newsletter.

ENGNW vs. The Competition

MetricenGeneBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$163.76M$5.09B$8.79B
Dividend YieldN/A3.50%5.04%4.07%
P/E RatioN/A329.4793.0914.02
Price / SalesN/A14,840.741,220.6787.41
Price / CashN/A11.6739.4936.27
Price / BookN/A7.056.936.33
Net IncomeN/A-$18.37M$118.83M$225.71M
7 Day Performance20.00%0.16%-1.74%-0.58%
1 Month Performance-17.14%8.26%-3.60%1.49%
1 Year PerformanceN/A25.75%31.91%27.23%

Related Companies and Tools


This page (NASDAQ:ENGNW) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners